Welcome

Spread the word:

Share
Tweet

Welcome

At Ultragenyx, the patient advocacy team is passionate about educating and supporting you: patients, families and caregivers affected by rare and ultra-rare diseases. Through this site you can find valuable resources, hear from others who live with rare diseases, and learn more about our commitment to the rare disease patient community.

Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases.

We understand the challenges facing many rare disease communities, including a lack of information and treatment options. The advocacy team works with patient groups to provide communities with educational materials, and to ensure patients’ needs are shared within our company to guide our work.

In the performance of our duties as representatives of the Ultragenyx Patient Advocacy team, we follow the PhRMA Principles on Interactions with Patient Organizations and the BIO Guiding Principles for Interaction with Patient Advocacy Organizations.

We hope to be a valuable resource on your journey with a rare disease.

Jessica Riviere, MHS
Vice President, Patient Advocacy, Patient Engagement, Global Medical Affairs
Ultragenyx Pharmaceutical Inc.
Kim Cohee, MS, CGC
Director, Patient Advocacy, Global Medical Affairs
Ultragenyx Pharmaceutical Inc.
Kristin Smith
Director, Patient Advocacy, Global Medical Affairs
Ultragenyx Pharmaceutical Inc.
Tom Pulles, MD
Vice President, EU Medical Affairs, Patient Advocacy
Ultragenyx Europe GmbH Basel, Switzerland
Kristin Voorhees, MA
Associate Director, Patient Advocacy, Global Medical Affairs
Ultragenyx Pharmaceutical Inc.
Belen Gonzalez Sutil, MA
Patient Advocacy Manager
Ultragenyx Latin America Argentina

  • Would you like to be updated as we post new patient journeys and resources?

    Join our mailing list

      I am most interested in:


      You are now signing up to receive email updates and news from Ultragenyx. The emails you will receive are not intended to provide you with healthcare advice. Ultragenyx will not and does not provide healthcare advice. By registering for this email service, you understand that you are not disclosing any personal, private health information to Ultragenyx.

      You must be 18 years of age or older and a resident of the United States or its territories to register. By registering to receive these emails, you certify that you are 18 years of age or older, reside in the United States or its territories and are granting permission to receive general updates and news from Patient Advocacy at Ultragenyx.

      By providing your information you agree to allow Ultragenyx and its agents to collect the name and email address provided and to be contacted by Ultragenyx and its agents using this information in the future. Furthermore, you are agreeing that Ultragenyx and its agents may contact you by email. Ultragenyx will not sell, rent or otherwise distribute your name and email address provided.